{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:17:21Z","timestamp":1777886241649,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.lanwpc.2026.101838","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:01:41Z","timestamp":1774065701000},"page":"101838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mass hepatitis C virus screening among persons in custody in Hong Kong: a modelling cost-effectiveness analysis based on a prospective cohort study"],"prefix":"10.1016","volume":"69","author":[{"given":"Zonglin","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Tai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-7725","authenticated-orcid":false,"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-3935","authenticated-orcid":false,"given":"Lung-Yi","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lanwpc.2026.101838_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101838_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coviro.2015.09.003","article-title":"How do persistent infections with hepatitis C virus cause liver cancer?","volume":"14","author":"Mitchell","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"1 Suppl","key":"10.1016\/j.lanwpc.2026.101838_bib3","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101838_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","article-title":"Breakthroughs in hepatitis C research: from discovery to cure","volume":"19","author":"Manns","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101838_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.04.027","article-title":"Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030","volume":"17","author":"Ou","year":"2024","journal-title":"J Infect Public Health"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101838_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.35772\/ghm.2021.01075","article-title":"Achieving WHO target of HCV control in Hong Kong: challenges and strategies","volume":"3","author":"Wang","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.lanwpc.2026.101838_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104568","article-title":"Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: barriers and facilitators","volume":"132","author":"Mak","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"11","key":"10.1016\/j.lanwpc.2026.101838_bib10","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/liv.13926","article-title":"Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong","volume":"38","author":"Hui","year":"2018","journal-title":"Liver Int"},{"issue":"10049","key":"10.1016\/j.lanwpc.2026.101838_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(16)30769-3","article-title":"Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners","volume":"388","author":"Kamarulzaman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2026.101838_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(25)02165-8","article-title":"THU-222 development of a hepatitis C infection integrated care model for prisoners in Chinese population","volume":"82","author":"Mak","year":"2025","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101838_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12916-020-01680-0","article-title":"Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination","volume":"18","author":"Akiyama","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101838_bib15","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1186\/s12889-022-14623-6","article-title":"Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis","volume":"22","author":"Busschots","year":"2022","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101838_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.70027","article-title":"Cost-effectiveness of universal screen-and-treat strategies for reducing morbidity and mortality of chronic hepatitis B in a high-endemicity city","volume":"32","author":"Wong","year":"2025","journal-title":"J Viral Hepat"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101838_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jval.2025.04.2158","article-title":"Economic evaluation results are substantially affected by parameter input correlation","volume":"28","author":"Barker","year":"2025","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101838_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.13537","article-title":"Individual- and area-level incarceration and mortality","volume":"8","author":"Khatri","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101838_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101838_bib21","article-title":"Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population","volume":"6","author":"Mongale","year":"2024","journal-title":"JHEP Rep"},{"issue":"3\u20134","key":"10.1016\/j.lanwpc.2026.101838_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1108\/IJPH-07-2016-0028","article-title":"Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health","volume":"13","author":"Morris","year":"2017","journal-title":"Int J Prison Health"},{"key":"10.1016\/j.lanwpc.2026.101838_bib23","article-title":"Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis","volume":"36","author":"Shih","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101838_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","article-title":"Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework","volume":"6","author":"Akiyama","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101838_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/21501319231186500","article-title":"Unveiling the significance and challenges of integrating prevention levels in healthcare practice","volume":"14","author":"AbdulRaheem","year":"2023","journal-title":"J Prim Care Community Health"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101838_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/v14030497","article-title":"The importance of prisons in achieving hepatitis C elimination: insights from the Australian experience","volume":"14","author":"Winter","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.lanwpc.2026.101838_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101810","article-title":"Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019","volume":"56","author":"van Santen","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"Suppl 3","key":"10.1016\/j.lanwpc.2026.101838_bib28","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/infdis\/jiac446","article-title":"HCV microelimination for high-risk special populations","volume":"228","author":"Huang","year":"2023","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101838_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101838_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","article-title":"A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:30:54Z","timestamp":1777606254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S2666606526000428"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101838","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mass hepatitis C virus screening among persons in custody in Hong Kong: a modelling cost-effectiveness analysis based on a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101838"}}